This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Save the date!
November 6–8, 2023Munich, Germany

Hidetoshi Tahara
Vice President at Hiroshima University


Hidetoshi Tahara is Vice President (Academia-Government-Industry Collaboration) and Professor of the Department of Cellular and Molecular Biology, Hiroshima University.

He has been researching cell senescence, immortalization, and canceration, as well as telomeres and microRNAs. Recently, he has succeeded in developing nucleic acid medicine using microRNA, started a first-in-human doctor-initiated clinical trial targeting malignant pleural mesothelioma in January of this year, and administered it to humans. He has established a new start-up called PURMX Therapeutics, Inc. and is trying to implement drug discovery using microRNA.  He has won the special award for EY Entrepreneur of The Year 2022 Japan and the special award for Academic Startups 2022.  He has launched the Hiroshima Love it Consortium last year and launched a healthy longevity project to coordinate with the health longevity agenda. He aims it to be a consortium where everyone who gathers can enjoy win-win through innovation in industry-academia collaboration.

Hidetoshi Tahara's Network

Agenda Sessions

  • Co-create the next value with bio ecosystems in Japan